Domov › Atopični dermatitis (ekcem) › Kalifornija

Klinične študije za Atopični dermatitis (ekcem) v Kalifornija

30 študij za Atopični dermatitis (ekcem) išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

First OC Dermatology, Irvine

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–72 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06808477

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Kern Research, Inc.- Site Number : 8400047, Bakersfield
Center for Dermatology Clinical Research- Site Number : 8400014, Fremont
Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
in še 4

Vključevanje udeležencevOpazovalna študija

Starost 12 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Fountain Valley
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Sacramento
in še 2

Vključevanje udeležencevFaza 2

Starost 18–100 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Beverly Hills
Enveda Investigative Site, Fremont
Enveda Investigative Site, San Diego
in še 3

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07298395

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

Alliance Clinical West Hills (Focus Clinical Research), West Hills

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07527923

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
University of California, San Diego/ Rady Children's Hospital - San Diego, San Diego

Vključevanje udeležencevFaza 3

Starost 2–11 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06807281

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Marvel Clinical Research, Huntington Beach
Metropolis Dermatology - DTLA, Los Angeles
Northridge Clinical Trials, Northridge
in še 1

Vključevanje udeležencevFaza 2

Starost 18–64 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Fountain Valley
Investigational Site, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07003425

The Impact of Dietary Salt on the Severity of Eczema

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07447063

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

UCSF Mt Zion Campus, San Francisco
San Francisco VA Medical Center, San Francisco

Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07487831

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

UCLA Division of Dermatology, Los Angeles
Dermatology Research Associate, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07223697

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Northridge Clinical Trials, Northridge

Vključevanje udeležencevFaza 3

Starost 12 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07765888

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Marvel Research, LLC, Huntington Beach
Metropolis Dermatology, Los Angeles
Dermatology Research Associates, Los Angeles
in še 4

Vključevanje udeležencevFaza 2

Starost 18–65 · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07599813

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Allergy and Asthma Medical Group and Research Center, San Diego

Vključevanje udeležencevOpazovalna študija

Starost 12 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06899204

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Integrative Skin Science and Research, Sacramento

Vključevanje udeležencevFaza 4

Starost 12 in več · Vsi spoli · Posodobljeno 13. avg. 2026 · NCT07560618

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 1, Lancaster
Inmagene Site 23, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18–74 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Encinitas
Enveda Investigative Site, Los Angeles
Enveda Investigative Site, Northridge

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT07643766

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Stanford University School of Medicine /ID# 269622, Palo Alto
Integrative Skin Science and Research /ID# 265108, Sacramento

Vključevanje udeležencevFaza 3

Starost 2–11 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06461897

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Anaheim Clinical Trials, LLC, Anaheim
TCR Medical Corporation, San Diego

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–70 · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06564389

Sodium in the Skin and Atopic Dermatitis

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 50 in več · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT06998446

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Leo Pharma Investigational site, Palo Alto
Leo Pharma Investigational site, Sacramento
Leo Pharma Investigational site, San Diego

Vključevanje udeležencevFaza 3

6 Months – 11 Years · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Exalt Clinical Research /ID# 281611, Chula Vista
Private Practice - Dr. Tooraj Raoof /ID# 263849, Encino
First OC Dermatology /ID# 263349, Fountain Valley
in še 8

Vključevanje udeležencevFaza 3

Starost 18–63 · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT06389136

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

University of California, San Diego: Dermatology Clinical Trials Unit, San Diego

Vključevanje udeležencevFaza 1

Starost 6 in več · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT06504160

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

First OC Dermatology, Fountain Valley
Center for Dermatology Clinical Research, Inc., Fremont
California Allergy and Asthma Medical Group, Los Angeles
in še 1

Vključevanje udeležencevFaza 2

Starost 18–65 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT06397911

Molecular Signatures of Cutaneous Dupilumab Response

University of California, San Francisco, San Francisco

Vključevanje udeležencevFaza 4

Starost 18 in več · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT05858619

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Marvel Clinical Research, Huntington Beach
California Allergy and Asthma Medical Group, Los Angeles
University Dermatology Trials, INC., Newport Beach
in še 4

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 4. maj 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site - 7074, Corona
Galderma Investigational Site 8636, Fountain Valley
Galderma Investigational Site 8224, Fremont
in še 4

Vključevanje udeležencevOpazovalna študija

Starost 12 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT06988605

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Corvus Clinical Trials, South San Francisco

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 5. mar. 2026 · NCT07441395

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

University of California San Diego (UCSD), La Jolla

Vključevanje udeležencevOpazovalna študija

Vse starosti · Ženske · Posodobljeno 28. jan. 2025 · NCT05938478

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Physioseq, LLC /ID# 267266, Sacramento

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 24. jan. 2025 · NCT06524635

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.